RobertW.BuchananMD

Psychiatry • Catonsville, MD

Professor, Psychiatry, University of Maryland School of Medicine

Join to view full profile

Dr. Buchanan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Buchanan's full profile

Already have an account?

Office
Spring Grove Hospital Grounds
Maple and Locust Streets
Catonsville, MD 21228
Phone+1 410-402-7876

Fax+1 410-402-7198

Education & Training

George Washington UniversityResidency, Psychiatry, 1980 - 1984
Rutgers New Jersey Medical SchoolClass of 1980

Certifications & Licensure

MD State Medical License 1984 - 2026
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine Start of enrollment: 2001 Dec 01
Completed
Phase 4
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia Start of enrollment: 2002 May 01
Completed
Phase 4
Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia Start of enrollment: 2007 Jan 01
Completed
Phase 4
Treatment Study for Cognitive Deficits in Schizophrenia Start of enrollment: 2007 Jul 01
Completed
Phase 2
The Effects of Rimonabant, on Weight and Metabolic Risk Factors Start of enrollment: 2007 Nov 01
Terminated
Phase 2
Effects of Oxytocin Nasal Spray on Social Affiliation Start of enrollment: 2009 Oct 01
Completed
Phase 2
Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia Start of enrollment: 2010 Feb 01
Completed
Phase 2
Salsalate for Insulin Resistance in Schizophrenia Start of enrollment: 2010 Aug 01
Completed
Not Applicable
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults Start of enrollment: 2011 Aug 01
Completed
Phase 2
Anti-Inflammatory Treatment of Schizophrenia Start of enrollment: 2012 Jun 01
Completed
Not Applicable
Oxytocin and CBSST for People With Schizophrenia Start of enrollment: 2014 Jan 01
Completed
Not Applicable
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia Start of enrollment: 2014 Mar 26
Completed
Phase 2
Tryptophan MRI in People With Schizophrenia and Healthy Controls Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Oxytocin, Emotions and Mirror Neurons Start of enrollment: 2014 Oct 01
Completed
Early Phase 1
Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia Start of enrollment: 2018 Dec 01
Active, not recruiting
Phase 2, Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

641 citations
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D. Howes, Robert A. McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J.M. van Beveren
The American Journal of Psychiatry. 2017-03-01
45 citations
The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients.
Alan Breier, Robert W. Buchanan
Life Sciences. 1992-01-01
6 citations
Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions.
Aristotle N Voineskos, Colin Hawco, Nicholas H Neufeld, Jessica A Turner, Stephanie H Ameis
World Psychiatry. 2024-02-01

Lectures

Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...
UC Davis Health System, Sacramento, California - 9/13/2012

Other

Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...
Robert Buchanan, MD, Schizophrenia Bulletin
https://www.doximity.com/articles/19cb6ea7-83a0-45e3-8fd1-8be0f0ddd718
UpToDate, Wolters Kluwer Health - 2011-10-10
Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...
Robert Buchanan, MD, Schizophrenia Bulletin
https://www.doximity.com/articles/19cb6ea7-83a0-45e3-8fd1-8be0f0ddd718
UpToDate, Wolters Kluwer Health - 2012-11-08

Press Mentions

Treating Schizophrenia SuccessfullyOctober 8th, 2018
UM SOM Professor of Psychiatry Recognized for Innovative and Promising Research in SchizophreniaOctober 31st, 2017
'Impressive' New Data on Novel Schizophrenia Hopeful KarXTMay 14th, 2024

Grant Support

Assessment CoreNational Institute Of Mental Health1998–2002